Exelixis (EXEL) Net Margin (2010 - 2026)
Exelixis (EXEL) recorded Net Margin of 33.73% in Q2 2027, up 1.20 percentage points from 32.53% a year earlier but down 0.73 percentage points from the prior quarter.
Powered by 
Analysis
Exelixis (EXEL) Net Margin (2010 - 2026) Analysis & Trends
On a TTM basis, Exelixis' Net Margin came in at 35.33% as of Jul 3, 2026, up 8.32 percentage points year-over-year.
- Annual Net Margin has a five-year change of +17.63 percentage points (FY2021 to FY2026).
- Across earlier years, Net Margin came in at 24.04% in FY2025, 11.35% in FY2023 (+0.04 pp) and 11.31% in FY2022 (-4.79 pp).
- Quarterly Net Margin has ranged from 8.78% in Q1 2025 to 40.85% in Q4 2026 over the past five years.
- On a year-over-year basis, Net Margin has increased for four consecutive quarters, with an average year-over-year change of +8.43 percentage points over the last six quarters.
- Per Business Quant, the preceding three quarters came in at 34.46% (Q1 2027), 40.85% (Q4 2026) and 32.38% (Q3 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 21.27% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | -8.04% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 22.61% |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 18.81% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 23.62% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -134.51% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -1.65% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 32.99% |
| 10 | Exelixis | 14.60 Bn | 10.93 Bn | 608.03 Mn | 33.73% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 3, 2026 | 33.73% |
| Apr 3, 2026 | 34.46% |
| Jan 2, 2026 | 40.85% |
| Oct 3, 2025 | 32.38% |
| Jul 4, 2025 | 32.53% |
| Apr 4, 2025 | 28.74% |
| Jan 3, 2025 | 24.68% |
| Sep 27, 2024 | 21.87% |
| Jun 28, 2024 | 35.49% |
| Mar 29, 2024 | 8.78% |
| Dec 29, 2023 | 17.83% |
| Sep 29, 2023 | 0.22% |
| Jun 30, 2023 | 17.28% |
| Mar 31, 2023 | 9.79% |
| Dec 30, 2022 | -7.12% |
| Sep 30, 2022 | 17.78% |
| Jul 1, 2022 | 16.85% |
| Apr 1, 2022 | 19.26% |
| Oct 1, 2021 | 11.63% |
| Jul 2, 2021 | 24.95% |
API Access
Exelixis Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=EXEL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "EXEL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=EXEL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();